Pfizer, BioNTech file application for EU approval of Covid-19 vaccine

News Desk

United States’s Pfizer and its German partner BioNTech had applied for European Union (EU) regulatory approval for their Covid-19 vaccine, raising hopes that the first jabs could be administered in December.

According to media reports, this has been stated by both the companies in a statement on Tuesday.

The statement further stated that the two companies had submitted an application to the European Medicines Agency on Monday “for Conditional Marketing Authorization (CMA)” for their vaccine, after tests showed it was 95 percent effective against the novel Covid19 pandemic.

Pfizer and BioNTech said that if approved, the jab could potentially be rolled out “in Europe before the end of 2020.